Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with ?-interferon and ribavirin

Thumbnail Image

Date

2011-02-28

Authors










Journal Title

Journal ISSN

Volume Title

Publisher

Brieflands

DOI

https://doi.org/

Abstract

 

Description

Keywords

Citation

URI

https://brieflands.com/journals/hepatmon/articles/70255

Collections

Hepatitis Monthly

Endorsement

Review

Supplemented By

Referenced By